Loading Session...

Session 10

Session Information

12:35-12:55 PM EDT

Active Genetics Comes Alive

Ethan Bier, Stephen Hedrick, and Andanda Goldrath, University of California, San Diego

2016 Transformative Research Award

National Institute of Allergy and Infectious Diseases


12:55-1:15 PM EDT

Phasic Activity in Serotonin Neurons and Emotional Reactivity

Melissa Warden, Cornell University

2015 New Innovator Award

National Institute of Mental Health


1:15-1:35 PM EDT

Immunotherapy Directed Against Skin Cancer Precursors Prevents Skin Cancer

Shawn Demehri, Massachusetts General Hospital

2015 Early Independence Award

National Institute of Dental and Craniofacial Research, National Cancer Institute


Jun 11, 2021 12:35 PM - 01:35 PM(America/Detroit)
Venue : Session 10
20210611T1235 20210611T1335 America/Detroit Session 10

12:35-12:55 PM EDT

Active Genetics Comes Alive

Ethan Bier, Stephen Hedrick, and Andanda Goldrath, University of California, San Diego

2016 Transformative Research Award

National Institute of Allergy and Infectious Diseases

12:55-1:15 PM EDT

Phasic Activity in Serotonin Neurons and Emotional Reactivity

Melissa Warden, Cornell University

2015 New Innovator Award

National Institute of Mental Health

1:15-1:35 PM EDT

Immunotherapy Directed Against Skin Cancer Precursors Prevents Skin Cancer

Shawn Demehri, Massachusetts General Hospital

2015 Early Independence Award

National Institute of Dental and Craniofacial Research, National Cancer Institute

Session 10 NIH Common Fund's 2021 High-Risk, High-Reward Research Symposium becky.miller2@nih.gov

Presentations

Active Genetics Comes Alive

Molecular and Cellular Biology 12:35 PM - 12:55 PM (America/Detroit) 2021/06/11 16:35:00 UTC - 2021/06/11 16:55:00 UTC
Active genetic elements are transmitted during reproduction at greater than expected Mendelian frequencies. Such "super-Mendelian" inheritance can be used for a variety of applications including: gene-drive systems for disseminating beneficial traits throughout populations (e.g., spreading immunizing factors that prevent mosquitoes from transmitting malarial parasites), reversing insecticide resistance, devising elements that can eliminate or inactivate gene drives, creating active genetic modifications that facilitate breeding by bypassing constraints imposed by independent assortment and linkage, and development of self-amplifying systems in bacteria to scrub antibiotic resistance factors from the environment or potentially from patients with chronic bacterial infections, and engineering next-generation genetic circuits for synthetic biology.
Presenters
EB
Ethan Bier
University Of California, San Diego
Co-Authors
SH
Stephen Hedrick
University Of California, San Diego

Phasic activity in serotonin neurons and emotional reactivity

Neuroscience 12:55 PM - 01:15 PM (America/Detroit) 2021/06/11 16:55:00 UTC - 2021/06/11 17:15:00 UTC
Survival depends on selecting and executing behaviors that are adaptive for the current environment. For example, a mouse should run from a rapidly looming hawk but should freeze if the hawk is coasting across the sky. Although serotonin has been implicated in adaptive, context-dependent behavior, environmental regulation of its functional role remains poorly understood. In mice, we found that brief stimulation of dorsal raphe serotonin neurons suppressed movement in low- and moderate-threat environments but induced escape behavior in high-threat environments, and that movement-related dorsal raphe serotonin neural dynamics inverted in high-threat environments. Although serotonin neurons appear to switch their functional role in different environments, we suggest an integrative framework in which phasic activity in serotonin neurons provokes a fast, environmentally appropriate emotional reaction – freeze at moderate threat, escape at high threat. This hypothesis cleanly explains our data, and has the potential to encompass a wide range of other environment- and internal state-dependent functions ascribed to this neuromodulatory system. We will discuss how this framework may have relevance for understanding the anti-anxiety effects of chronically administered selective serotonin reuptake inhibitors.

Click Here for Recorded Presentation
Presenters
MW
Melissa Warden
Cornell University

Immunotherapy Directed against Skin Cancer Precursors Prevents Skin Cancer

Infectious Diseases and Immunology 01:15 PM - 01:35 PM (America/Detroit) 2021/06/11 17:15:00 UTC - 2021/06/11 17:35:00 UTC
Skin cancer is the most common type of cancer. Although ultraviolet radiation is its preventable risk factor, the incidence of skin cancer, including squamous cell carcinoma (SCC), has doubled over the last decade in the United States. Besides morbidity and mortality associated with skin cancer, skin cancer treatments represent a rising public health challenge with increasing complications and rising costs. Therefore, skin cancer prevention is urgently needed. To accomplish this goal, we developed topical calcipotriol plus 5-fluorouracil (5-FU) immunotherapy that effectively eliminated SCC precursors called actinic keratosis in a randomized double-blind clinical trial. Since, we performed a blinded prospective cohort study on its participants in order to determine the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention. Calcipotriol plus 5-FU combination induced tissue-resident memory T (TRM) cell formation in face and scalp skin, which was associated with significantly higher erythema scores compared to control groups (Vaseline plus 5-FU, p < 0.01). Importantly, more participants in the test cohort remained SCC-free over the > 1500-day follow-up period, and significantly fewer developed SCC on the treated face and scalp within 3 years (2 of 30 [7%] versus 11 of 40 [28%] in control group, hazard ratio 0.215 [95% CI: 0.048-0.972], p=0.032). Interestingly, we found more epidermal TRM cells persisting in the calcipotriol plus 5-FU-treated face and scalp skin compared with control months to years post treatment (p=0.0028). Our findings demonstrate that a short course of a topical immunotherapy that induces T cell immunity and effectively eliminates actinic keratosis can significantly lower the long-term risk of SCC. Our research substantiates a previously unrecognized concept that immunotherapy against premalignant lesions can be used to prevent cancer development and recurrence in high-risk patients.
Presenters
SD
Shawn Demehri
Massachusetts General Hospital
32 visits

Session Participants

User Online
Session speakers, moderators & attendees
Massachusetts General Hospital
Cornell University
University of California, San Diego
NIH/Center for Scientific Review
University of California San Diego
Northwestern University
NIH/NHGRI
University of Pittsburgh
Boston College
+67 more attendees. View All
108 attendees saved this session

Session Chat

Live Chat
Chat with participants attending this session

Questions & Answers

Answered
Submit questions for the presenters

Need Help?

Technical Issues?

If you're experiencing playback problems, try adjusting the quality or refreshing the page.

Questions for Speakers?

Use the Q&A tab to submit questions that may be addressed in follow-up sessions.